1 Study Coverage
    1.1 Mucopolysaccharidosis II Product Introduction
    1.2 Market by Type
        1.2.1 Global Mucopolysaccharidosis II Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 JR-141
        1.2.3 EGT-301
        1.2.4 DUOC-01
        1.2.5 AGT-182
        1.2.6 JR-032
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Mucopolysaccharidosis II Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Research Center
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Mucopolysaccharidosis II Sales Estimates and Forecasts 2017-2028
    2.2 Global Mucopolysaccharidosis II Revenue Estimates and Forecasts 2017-2028
    2.3 Global Mucopolysaccharidosis II Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Mucopolysaccharidosis II Sales by Region
        2.4.1 Global Mucopolysaccharidosis II Sales by Region (2017-2022)
        2.4.2 Global Sales Mucopolysaccharidosis II by Region (2023-2028)
    2.5 Global Mucopolysaccharidosis II Revenue by Region
        2.5.1 Global Mucopolysaccharidosis II Revenue by Region (2017-2022)
        2.5.2 Global Mucopolysaccharidosis II Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Mucopolysaccharidosis II Sales by Manufacturers
        3.1.1 Global Top Mucopolysaccharidosis II Manufacturers by Sales (2017-2022)
        3.1.2 Global Mucopolysaccharidosis II Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mucopolysaccharidosis II in 2021
    3.2 Global Mucopolysaccharidosis II Revenue by Manufacturers
        3.2.1 Global Mucopolysaccharidosis II Revenue by Manufacturers (2017-2022)
        3.2.2 Global Mucopolysaccharidosis II Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Mucopolysaccharidosis II Revenue in 2021
    3.3 Global Mucopolysaccharidosis II Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Mucopolysaccharidosis II Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Mucopolysaccharidosis II Sales by Type
        4.1.1 Global Mucopolysaccharidosis II Historical Sales by Type (2017-2022)
        4.1.2 Global Mucopolysaccharidosis II Forecasted Sales by Type (2023-2028)
        4.1.3 Global Mucopolysaccharidosis II Sales Market Share by Type (2017-2028)
    4.2 Global Mucopolysaccharidosis II Revenue by Type
        4.2.1 Global Mucopolysaccharidosis II Historical Revenue by Type (2017-2022)
        4.2.2 Global Mucopolysaccharidosis II Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Mucopolysaccharidosis II Revenue Market Share by Type (2017-2028)
    4.3 Global Mucopolysaccharidosis II Price by Type
        4.3.1 Global Mucopolysaccharidosis II Price by Type (2017-2022)
        4.3.2 Global Mucopolysaccharidosis II Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Mucopolysaccharidosis II Sales by Application
        5.1.1 Global Mucopolysaccharidosis II Historical Sales by Application (2017-2022)
        5.1.2 Global Mucopolysaccharidosis II Forecasted Sales by Application (2023-2028)
        5.1.3 Global Mucopolysaccharidosis II Sales Market Share by Application (2017-2028)
    5.2 Global Mucopolysaccharidosis II Revenue by Application
        5.2.1 Global Mucopolysaccharidosis II Historical Revenue by Application (2017-2022)
        5.2.2 Global Mucopolysaccharidosis II Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Mucopolysaccharidosis II Revenue Market Share by Application (2017-2028)
    5.3 Global Mucopolysaccharidosis II Price by Application
        5.3.1 Global Mucopolysaccharidosis II Price by Application (2017-2022)
        5.3.2 Global Mucopolysaccharidosis II Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Mucopolysaccharidosis II Market Size by Type
        6.1.1 North America Mucopolysaccharidosis II Sales by Type (2017-2028)
        6.1.2 North America Mucopolysaccharidosis II Revenue by Type (2017-2028)
    6.2 North America Mucopolysaccharidosis II Market Size by Application
        6.2.1 North America Mucopolysaccharidosis II Sales by Application (2017-2028)
        6.2.2 North America Mucopolysaccharidosis II Revenue by Application (2017-2028)
    6.3 North America Mucopolysaccharidosis II Market Size by Country
        6.3.1 North America Mucopolysaccharidosis II Sales by Country (2017-2028)
        6.3.2 North America Mucopolysaccharidosis II Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Mucopolysaccharidosis II Market Size by Type
        7.1.1 Europe Mucopolysaccharidosis II Sales by Type (2017-2028)
        7.1.2 Europe Mucopolysaccharidosis II Revenue by Type (2017-2028)
    7.2 Europe Mucopolysaccharidosis II Market Size by Application
        7.2.1 Europe Mucopolysaccharidosis II Sales by Application (2017-2028)
        7.2.2 Europe Mucopolysaccharidosis II Revenue by Application (2017-2028)
    7.3 Europe Mucopolysaccharidosis II Market Size by Country
        7.3.1 Europe Mucopolysaccharidosis II Sales by Country (2017-2028)
        7.3.2 Europe Mucopolysaccharidosis II Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Mucopolysaccharidosis II Market Size by Type
        8.1.1 Asia Pacific Mucopolysaccharidosis II Sales by Type (2017-2028)
        8.1.2 Asia Pacific Mucopolysaccharidosis II Revenue by Type (2017-2028)
    8.2 Asia Pacific Mucopolysaccharidosis II Market Size by Application
        8.2.1 Asia Pacific Mucopolysaccharidosis II Sales by Application (2017-2028)
        8.2.2 Asia Pacific Mucopolysaccharidosis II Revenue by Application (2017-2028)
    8.3 Asia Pacific Mucopolysaccharidosis II Market Size by Region
        8.3.1 Asia Pacific Mucopolysaccharidosis II Sales by Region (2017-2028)
        8.3.2 Asia Pacific Mucopolysaccharidosis II Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Mucopolysaccharidosis II Market Size by Type
        9.1.1 Latin America Mucopolysaccharidosis II Sales by Type (2017-2028)
        9.1.2 Latin America Mucopolysaccharidosis II Revenue by Type (2017-2028)
    9.2 Latin America Mucopolysaccharidosis II Market Size by Application
        9.2.1 Latin America Mucopolysaccharidosis II Sales by Application (2017-2028)
        9.2.2 Latin America Mucopolysaccharidosis II Revenue by Application (2017-2028)
    9.3 Latin America Mucopolysaccharidosis II Market Size by Country
        9.3.1 Latin America Mucopolysaccharidosis II Sales by Country (2017-2028)
        9.3.2 Latin America Mucopolysaccharidosis II Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Mucopolysaccharidosis II Market Size by Type
        10.1.1 Middle East and Africa Mucopolysaccharidosis II Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Mucopolysaccharidosis II Revenue by Type (2017-2028)
    10.2 Middle East and Africa Mucopolysaccharidosis II Market Size by Application
        10.2.1 Middle East and Africa Mucopolysaccharidosis II Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Mucopolysaccharidosis II Revenue by Application (2017-2028)
    10.3 Middle East and Africa Mucopolysaccharidosis II Market Size by Country
        10.3.1 Middle East and Africa Mucopolysaccharidosis II Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Mucopolysaccharidosis II Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Alexion Pharmaceuticals, Inc.
        11.1.1 Alexion Pharmaceuticals, Inc. Corporation Information
        11.1.2 Alexion Pharmaceuticals, Inc. Overview
        11.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Alexion Pharmaceuticals, Inc. Recent Developments
    11.2 AngioChem Inc.
        11.2.1 AngioChem Inc. Corporation Information
        11.2.2 AngioChem Inc. Overview
        11.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AngioChem Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AngioChem Inc. Recent Developments
    11.3 ArmaGen Inc.
        11.3.1 ArmaGen Inc. Corporation Information
        11.3.2 ArmaGen Inc. Overview
        11.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 ArmaGen Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 ArmaGen Inc. Recent Developments
    11.4 Bioasis Technologies Inc.
        11.4.1 Bioasis Technologies Inc. Corporation Information
        11.4.2 Bioasis Technologies Inc. Overview
        11.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Bioasis Technologies Inc. Recent Developments
    11.5 Green Cross Corporation
        11.5.1 Green Cross Corporation Corporation Information
        11.5.2 Green Cross Corporation Overview
        11.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Green Cross Corporation Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Green Cross Corporation Recent Developments
    11.6 Inventiva
        11.6.1 Inventiva Corporation Information
        11.6.2 Inventiva Overview
        11.6.3 Inventiva Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Inventiva Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Inventiva Recent Developments
    11.7 JCR Pharmaceuticals Co., Ltd.
        11.7.1 JCR Pharmaceuticals Co., Ltd. Corporation Information
        11.7.2 JCR Pharmaceuticals Co., Ltd. Overview
        11.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
    11.8 Laboratorios Del Dr. Esteve S.A.
        11.8.1 Laboratorios Del Dr. Esteve S.A. Corporation Information
        11.8.2 Laboratorios Del Dr. Esteve S.A. Overview
        11.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Laboratorios Del Dr. Esteve S.A. Recent Developments
    11.9 RegenxBio Inc.
        11.9.1 RegenxBio Inc. Corporation Information
        11.9.2 RegenxBio Inc. Overview
        11.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 RegenxBio Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 RegenxBio Inc. Recent Developments
    11.10 Sangamo BioSciences, Inc.
        11.10.1 Sangamo BioSciences, Inc. Corporation Information
        11.10.2 Sangamo BioSciences, Inc. Overview
        11.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Sangamo BioSciences, Inc. Recent Developments
    11.11 Takeda
        11.11.1 Takeda Corporation Information
        11.11.2 Takeda Overview
        11.11.3 Takeda Mucopolysaccharidosis II Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Takeda Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Mucopolysaccharidosis II Industry Chain Analysis
    12.2 Mucopolysaccharidosis II Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Mucopolysaccharidosis II Production Mode & Process
    12.4 Mucopolysaccharidosis II Sales and Marketing
        12.4.1 Mucopolysaccharidosis II Sales Channels
        12.4.2 Mucopolysaccharidosis II Distributors
    12.5 Mucopolysaccharidosis II Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Mucopolysaccharidosis II Industry Trends
    13.2 Mucopolysaccharidosis II Market Drivers
    13.3 Mucopolysaccharidosis II Market Challenges
    13.4 Mucopolysaccharidosis II Market Restraints
14 Key Findings in The Global Mucopolysaccharidosis II Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Mucopolysaccharidosis II Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of JR-141
    Table 3. Major Manufacturers of EGT-301
    Table 4. Major Manufacturers of DUOC-01
    Table 5. Major Manufacturers of AGT-182
    Table 6. Major Manufacturers of JR-032
    Table 7. Major Manufacturers of Others
    Table 8. Global Mucopolysaccharidosis II Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Mucopolysaccharidosis II Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Mucopolysaccharidosis II Sales by Region (2017-2022) & (K Pcs)
    Table 11. Global Mucopolysaccharidosis II Sales Market Share by Region (2017-2022)
    Table 12. Global Mucopolysaccharidosis II Sales by Region (2023-2028) & (K Pcs)
    Table 13. Global Mucopolysaccharidosis II Sales Market Share by Region (2023-2028)
    Table 14. Global Mucopolysaccharidosis II Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Mucopolysaccharidosis II Revenue Market Share by Region (2017-2022)
    Table 16. Global Mucopolysaccharidosis II Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Mucopolysaccharidosis II Revenue Market Share by Region (2023-2028)
    Table 18. Global Mucopolysaccharidosis II Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 19. Global Mucopolysaccharidosis II Sales Share by Manufacturers (2017-2022)
    Table 20. Global Mucopolysaccharidosis II Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Mucopolysaccharidosis II Revenue Share by Manufacturers (2017-2022)
    Table 22. Mucopolysaccharidosis II Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 23. Global Mucopolysaccharidosis II Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Mucopolysaccharidosis II by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucopolysaccharidosis II as of 2021)
    Table 25. Mucopolysaccharidosis II Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Mucopolysaccharidosis II Product Offered
    Table 27. Date of Manufacturers Enter into Mucopolysaccharidosis II Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)
    Table 30. Global Mucopolysaccharidosis II Sales by Type (2023-2028) & (K Pcs)
    Table 31. Global Mucopolysaccharidosis II Sales Share by Type (2017-2022)
    Table 32. Global Mucopolysaccharidosis II Sales Share by Type (2023-2028)
    Table 33. Global Mucopolysaccharidosis II Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Mucopolysaccharidosis II Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Mucopolysaccharidosis II Revenue Share by Type (2017-2022)
    Table 36. Global Mucopolysaccharidosis II Revenue Share by Type (2023-2028)
    Table 37. Mucopolysaccharidosis II Price by Type (2017-2022) & (USD/Pcs)
    Table 38. Global Mucopolysaccharidosis II Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 39. Global Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)
    Table 40. Global Mucopolysaccharidosis II Sales by Application (2023-2028) & (K Pcs)
    Table 41. Global Mucopolysaccharidosis II Sales Share by Application (2017-2022)
    Table 42. Global Mucopolysaccharidosis II Sales Share by Application (2023-2028)
    Table 43. Global Mucopolysaccharidosis II Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Mucopolysaccharidosis II Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Mucopolysaccharidosis II Revenue Share by Application (2017-2022)
    Table 46. Global Mucopolysaccharidosis II Revenue Share by Application (2023-2028)
    Table 47. Mucopolysaccharidosis II Price by Application (2017-2022) & (USD/Pcs)
    Table 48. Global Mucopolysaccharidosis II Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 49. North America Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)
    Table 50. North America Mucopolysaccharidosis II Sales by Type (2023-2028) & (K Pcs)
    Table 51. North America Mucopolysaccharidosis II Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Mucopolysaccharidosis II Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)
    Table 54. North America Mucopolysaccharidosis II Sales by Application (2023-2028) & (K Pcs)
    Table 55. North America Mucopolysaccharidosis II Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Mucopolysaccharidosis II Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Mucopolysaccharidosis II Sales by Country (2017-2022) & (K Pcs)
    Table 58. North America Mucopolysaccharidosis II Sales by Country (2023-2028) & (K Pcs)
    Table 59. North America Mucopolysaccharidosis II Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Mucopolysaccharidosis II Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)
    Table 62. Europe Mucopolysaccharidosis II Sales by Type (2023-2028) & (K Pcs)
    Table 63. Europe Mucopolysaccharidosis II Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Mucopolysaccharidosis II Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)
    Table 66. Europe Mucopolysaccharidosis II Sales by Application (2023-2028) & (K Pcs)
    Table 67. Europe Mucopolysaccharidosis II Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Mucopolysaccharidosis II Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Mucopolysaccharidosis II Sales by Country (2017-2022) & (K Pcs)
    Table 70. Europe Mucopolysaccharidosis II Sales by Country (2023-2028) & (K Pcs)
    Table 71. Europe Mucopolysaccharidosis II Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Mucopolysaccharidosis II Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)
    Table 74. Asia Pacific Mucopolysaccharidosis II Sales by Type (2023-2028) & (K Pcs)
    Table 75. Asia Pacific Mucopolysaccharidosis II Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Mucopolysaccharidosis II Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)
    Table 78. Asia Pacific Mucopolysaccharidosis II Sales by Application (2023-2028) & (K Pcs)
    Table 79. Asia Pacific Mucopolysaccharidosis II Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Mucopolysaccharidosis II Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Mucopolysaccharidosis II Sales by Region (2017-2022) & (K Pcs)
    Table 82. Asia Pacific Mucopolysaccharidosis II Sales by Region (2023-2028) & (K Pcs)
    Table 83. Asia Pacific Mucopolysaccharidosis II Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Mucopolysaccharidosis II Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)
    Table 86. Latin America Mucopolysaccharidosis II Sales by Type (2023-2028) & (K Pcs)
    Table 87. Latin America Mucopolysaccharidosis II Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Mucopolysaccharidosis II Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)
    Table 90. Latin America Mucopolysaccharidosis II Sales by Application (2023-2028) & (K Pcs)
    Table 91. Latin America Mucopolysaccharidosis II Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Mucopolysaccharidosis II Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Mucopolysaccharidosis II Sales by Country (2017-2022) & (K Pcs)
    Table 94. Latin America Mucopolysaccharidosis II Sales by Country (2023-2028) & (K Pcs)
    Table 95. Latin America Mucopolysaccharidosis II Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Mucopolysaccharidosis II Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Mucopolysaccharidosis II Sales by Type (2017-2022) & (K Pcs)
    Table 98. Middle East and Africa Mucopolysaccharidosis II Sales by Type (2023-2028) & (K Pcs)
    Table 99. Middle East and Africa Mucopolysaccharidosis II Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Mucopolysaccharidosis II Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Mucopolysaccharidosis II Sales by Application (2017-2022) & (K Pcs)
    Table 102. Middle East and Africa Mucopolysaccharidosis II Sales by Application (2023-2028) & (K Pcs)
    Table 103. Middle East and Africa Mucopolysaccharidosis II Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Mucopolysaccharidosis II Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2017-2022) & (K Pcs)
    Table 106. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2023-2028) & (K Pcs)
    Table 107. Middle East and Africa Mucopolysaccharidosis II Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Mucopolysaccharidosis II Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Alexion Pharmaceuticals, Inc. Corporation Information
    Table 110. Alexion Pharmaceuticals, Inc. Description and Major Businesses
    Table 111. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 112. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Alexion Pharmaceuticals, Inc. Recent Developments
    Table 114. AngioChem Inc. Corporation Information
    Table 115. AngioChem Inc. Description and Major Businesses
    Table 116. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 117. AngioChem Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. AngioChem Inc. Recent Developments
    Table 119. ArmaGen Inc. Corporation Information
    Table 120. ArmaGen Inc. Description and Major Businesses
    Table 121. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 122. ArmaGen Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. ArmaGen Inc. Recent Developments
    Table 124. Bioasis Technologies Inc. Corporation Information
    Table 125. Bioasis Technologies Inc. Description and Major Businesses
    Table 126. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 127. Bioasis Technologies Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Bioasis Technologies Inc. Recent Developments
    Table 129. Green Cross Corporation Corporation Information
    Table 130. Green Cross Corporation Description and Major Businesses
    Table 131. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 132. Green Cross Corporation Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Green Cross Corporation Recent Developments
    Table 134. Inventiva Corporation Information
    Table 135. Inventiva Description and Major Businesses
    Table 136. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 137. Inventiva Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Inventiva Recent Developments
    Table 139. JCR Pharmaceuticals Co., Ltd. Corporation Information
    Table 140. JCR Pharmaceuticals Co., Ltd. Description and Major Businesses
    Table 141. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 142. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. JCR Pharmaceuticals Co., Ltd. Recent Developments
    Table 144. Laboratorios Del Dr. Esteve S.A. Corporation Information
    Table 145. Laboratorios Del Dr. Esteve S.A. Description and Major Businesses
    Table 146. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 147. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Laboratorios Del Dr. Esteve S.A. Recent Developments
    Table 149. RegenxBio Inc. Corporation Information
    Table 150. RegenxBio Inc. Description and Major Businesses
    Table 151. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 152. RegenxBio Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. RegenxBio Inc. Recent Developments
    Table 154. Sangamo BioSciences, Inc. Corporation Information
    Table 155. Sangamo BioSciences, Inc. Description and Major Businesses
    Table 156. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 157. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Sangamo BioSciences, Inc. Recent Developments
    Table 159. Takeda Corporation Information
    Table 160. Takeda Description and Major Businesses
    Table 161. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 162. Takeda Mucopolysaccharidosis II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. Takeda Recent Developments
    Table 164. Key Raw Materials Lists
    Table 165. Raw Materials Key Suppliers Lists
    Table 166. Mucopolysaccharidosis II Distributors List
    Table 167. Mucopolysaccharidosis II Customers List
    Table 168. Mucopolysaccharidosis II Market Trends
    Table 169. Mucopolysaccharidosis II Market Drivers
    Table 170. Mucopolysaccharidosis II Market Challenges
    Table 171. Mucopolysaccharidosis II Market Restraints
    Table 172. Research Programs/Design for This Report
    Table 173. Key Data Information from Secondary Sources
    Table 174. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mucopolysaccharidosis II Product Picture
    Figure 3. Global Mucopolysaccharidosis II Market Share by Type in 2021 & 2028
    Figure 3. JR-141 Product Picture
    Figure 4. EGT-301 Product Picture
    Figure 5. DUOC-01 Product Picture
    Figure 6. AGT-182 Product Picture
    Figure 7. JR-032 Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Mucopolysaccharidosis II Market Share by Application in 2021 & 2028
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Research Center
    Figure 13. Others
    Figure 14. Mucopolysaccharidosis II Report Years Considered
    Figure 15. Global Mucopolysaccharidosis II Sales 2017-2028 (K Pcs)
    Figure 16. Global Mucopolysaccharidosis II Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Mucopolysaccharidosis II Revenue 2017-2028 (US$ Million)
    Figure 18. Global Mucopolysaccharidosis II Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Mucopolysaccharidosis II Sales Market Share by Region (2017-2022)
    Figure 20. Global Mucopolysaccharidosis II Sales Market Share by Region (2023-2028)
    Figure 21. North America Mucopolysaccharidosis II Sales YoY (2017-2028) & (K Pcs)
    Figure 22. North America Mucopolysaccharidosis II Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Mucopolysaccharidosis II Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Europe Mucopolysaccharidosis II Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Mucopolysaccharidosis II Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Asia-Pacific Mucopolysaccharidosis II Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Mucopolysaccharidosis II Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Latin America Mucopolysaccharidosis II Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Mucopolysaccharidosis II Sales YoY (2017-2028) & (K Pcs)
    Figure 30. Middle East & Africa Mucopolysaccharidosis II Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Mucopolysaccharidosis II Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Mucopolysaccharidosis II in the World: Market Share by Mucopolysaccharidosis II Revenue in 2021
    Figure 33. Global Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Mucopolysaccharidosis II Sales Market Share by Type (2017-2028)
    Figure 35. Global Mucopolysaccharidosis II Revenue Market Share by Type (2017-2028)
    Figure 36. Global Mucopolysaccharidosis II Sales Market Share by Application (2017-2028)
    Figure 37. Global Mucopolysaccharidosis II Revenue Market Share by Application (2017-2028)
    Figure 38. North America Mucopolysaccharidosis II Sales Market Share by Type (2017-2028)
    Figure 39. North America Mucopolysaccharidosis II Revenue Market Share by Type (2017-2028)
    Figure 40. North America Mucopolysaccharidosis II Sales Market Share by Application (2017-2028)
    Figure 41. North America Mucopolysaccharidosis II Revenue Market Share by Application (2017-2028)
    Figure 42. North America Mucopolysaccharidosis II Sales Share by Country (2017-2028)
    Figure 43. North America Mucopolysaccharidosis II Revenue Share by Country (2017-2028)
    Figure 44. U.S. Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Mucopolysaccharidosis II Sales Market Share by Type (2017-2028)
    Figure 47. Europe Mucopolysaccharidosis II Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Mucopolysaccharidosis II Sales Market Share by Application (2017-2028)
    Figure 49. Europe Mucopolysaccharidosis II Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Mucopolysaccharidosis II Sales Share by Country (2017-2028)
    Figure 51. Europe Mucopolysaccharidosis II Revenue Share by Country (2017-2028)
    Figure 52. Germany Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 53. France Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Mucopolysaccharidosis II Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Mucopolysaccharidosis II Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Mucopolysaccharidosis II Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Mucopolysaccharidosis II Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Mucopolysaccharidosis II Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Mucopolysaccharidosis II Revenue Share by Region (2017-2028)
    Figure 63. China Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 66. India Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Mucopolysaccharidosis II Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Mucopolysaccharidosis II Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Mucopolysaccharidosis II Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Mucopolysaccharidosis II Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Mucopolysaccharidosis II Sales Share by Country (2017-2028)
    Figure 78. Latin America Mucopolysaccharidosis II Revenue Share by Country (2017-2028)
    Figure 79. Mexico Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Mucopolysaccharidosis II Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Mucopolysaccharidosis II Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Mucopolysaccharidosis II Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Mucopolysaccharidosis II Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Mucopolysaccharidosis II Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Mucopolysaccharidosis II Revenue Share by Country (2017-2028)
    Figure 88. Turkey Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Mucopolysaccharidosis II Revenue (2017-2028) & (US$ Million)
    Figure 91. Mucopolysaccharidosis II Value Chain
    Figure 92. Mucopolysaccharidosis II Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed